FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912857720> ?p ?o ?g. }

• W2912857720 endingPage "430" @default.
• W2912857720 startingPage "425" @default.
• W2912857720 abstract "This is the fourth in a series of columns discussing the rational and targeted development of drugs to affect specific central nervous system (CNS) circuits in specific ways based on knowledge gained by molecular biology and the human genome project. The first column in this series described 6 CNS drugs with novel mechanisms of action developed over the last 25 years. The second column discussed differences between syndromic diagnoses as exemplified by the third through the fifth editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM III through DSM-5) and the new approach to psychiatric diagnoses championed by the National Institute of Mental Health in their Research Domain Criteria Initiative. The third column reviewed the last 9 years of drug development contrasting the development of drugs in other therapeutic areas (eg, cancer) with psychiatric and related CNS-active drugs. This column extends the discussion of modern drug development for psychiatric and other CNS-related indications, using the development of tasimelteon as an example of how modern drug development focuses rationally on novel targets of interest while simultaneously achieving “specificity.” Tasimelteon, which is indicated for the treatment of non-24-hour sleep-wake disorder, was developed to be a selective agonist at the melatonin MT1 and MT2 receptors, with limited or no effects at other pharmacologically relevant receptors and enzymes to minimize the potential for off-target effects (eg, nuisance side effects), toxicity, drug-drug interactions, and effects on oxidative drug metabolizing enzymes. The next column in this series will continue the discussion of the development of CNS drugs with novel mechanisms of action, using suvorexant, which targets orexin-1 and orexin-2 receptors, to illustrate the preclinical and human studies that were carried out to assess its safety as part of a successful new drug application." @default.
• W2912857720 created "2019-02-21" @default.
• W2912857720 creator A5089332899 @default.
• W2912857720 date "2017-11-01" @default.
• W2912857720 modified "2023-10-02" @default.
• W2912857720 title "CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes—Tasimelteon as an Example" @default.
• W2912857720 cites W120374126 @default.
• W2912857720 cites W1964256412 @default.
• W2912857720 cites W1983770667 @default.
• W2912857720 cites W1995717354 @default.
• W2912857720 cites W2008671752 @default.
• W2912857720 cites W2011214288 @default.
• W2912857720 cites W2018176533 @default.
• W2912857720 cites W2034264692 @default.
• W2912857720 cites W2041031046 @default.
• W2912857720 cites W2046307791 @default.
• W2912857720 cites W2054503257 @default.
• W2912857720 cites W2055699557 @default.
• W2912857720 cites W2075430620 @default.
• W2912857720 cites W2080853622 @default.
• W2912857720 cites W2083449354 @default.
• W2912857720 cites W2100876687 @default.
• W2912857720 cites W2115505876 @default.
• W2912857720 cites W2119434070 @default.
• W2912857720 cites W2131858154 @default.
• W2912857720 cites W2131950556 @default.
• W2912857720 cites W2135303822 @default.
• W2912857720 cites W2142622103 @default.
• W2912857720 cites W2156539373 @default.
• W2912857720 cites W2161731199 @default.
• W2912857720 cites W2750141743 @default.
• W2912857720 cites W2759749067 @default.
• W2912857720 cites W2914108029 @default.
• W2912857720 cites W4322701718 @default.
• W2912857720 doi "https://doi.org/10.1097/pra.0000000000000274" @default.
• W2912857720 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29303950" @default.
• W2912857720 hasPublicationYear "2017" @default.
• W2912857720 type Work @default.
• W2912857720 sameAs 2912857720 @default.
• W2912857720 citedByCount "7" @default.
• W2912857720 countsByYear W29128577202018 @default.
• W2912857720 countsByYear W29128577202022 @default.
• W2912857720 countsByYear W29128577202023 @default.
• W2912857720 crossrefType "journal-article" @default.
• W2912857720 hasAuthorship W2912857720A5089332899 @default.
• W2912857720 hasConcept C118552586 @default.
• W2912857720 hasConcept C134362201 @default.
• W2912857720 hasConcept C15744967 @default.
• W2912857720 hasConcept C169760540 @default.
• W2912857720 hasConcept C2778182776 @default.
• W2912857720 hasConcept C2780035454 @default.
• W2912857720 hasConcept C2781269140 @default.
• W2912857720 hasConcept C64903051 @default.
• W2912857720 hasConcept C71924100 @default.
• W2912857720 hasConcept C98274493 @default.
• W2912857720 hasConceptScore W2912857720C118552586 @default.
• W2912857720 hasConceptScore W2912857720C134362201 @default.
• W2912857720 hasConceptScore W2912857720C15744967 @default.
• W2912857720 hasConceptScore W2912857720C169760540 @default.
• W2912857720 hasConceptScore W2912857720C2778182776 @default.
• W2912857720 hasConceptScore W2912857720C2780035454 @default.
• W2912857720 hasConceptScore W2912857720C2781269140 @default.
• W2912857720 hasConceptScore W2912857720C64903051 @default.
• W2912857720 hasConceptScore W2912857720C71924100 @default.
• W2912857720 hasConceptScore W2912857720C98274493 @default.
• W2912857720 hasIssue "6" @default.
• W2912857720 hasLocation W29128577201 @default.
• W2912857720 hasLocation W29128577202 @default.
• W2912857720 hasOpenAccess W2912857720 @default.
• W2912857720 hasPrimaryLocation W29128577201 @default.
• W2912857720 hasRelatedWork W1603416295 @default.
• W2912857720 hasRelatedWork W1959407146 @default.
• W2912857720 hasRelatedWork W1988861809 @default.
• W2912857720 hasRelatedWork W2078153320 @default.
• W2912857720 hasRelatedWork W2080081537 @default.
• W2912857720 hasRelatedWork W2329258414 @default.
• W2912857720 hasRelatedWork W2681933021 @default.
• W2912857720 hasRelatedWork W2748952813 @default.
• W2912857720 hasRelatedWork W2899084033 @default.
• W2912857720 hasRelatedWork W3202735287 @default.
• W2912857720 hasVolume "23" @default.
• W2912857720 isParatext "false" @default.
• W2912857720 isRetracted "false" @default.
• W2912857720 magId "2912857720" @default.
• W2912857720 workType "article" @default.